Applying the risk/use equilibrium: use medicinal nicotine now for harm reduction: Figure 1
- 1 September 2001
- journal article
- Published by BMJ in Tobacco Control
- Vol. 10 (3) , 201-203
- https://doi.org/10.1136/tc.10.3.201
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- Risk of acute first myocardial infarction and use of nicotine patches in a general populationJournal of the American College of Cardiology, 2001
- Official cigarette tar tests are misleading: use a two-stage, compensating testThe Lancet, 2000
- Effects of nicotine nasal spray on atherogenic and thrombogenic factors during smoking cessationJournal of Internal Medicine, 1999
- Nicotine Safety and ToxicityPublished by Oxford University Press (OUP) ,1998
- Toxicity of Nicotine Replacement in Patients with Coronary Artery DiseasePublished by Oxford University Press (OUP) ,1998
- Dose-related cardiovascular and endocrine effects of transdermal nicotine*Clinical Pharmacology & Therapeutics, 1998
- The Emerging Market for Long-term Nicotine MaintenanceJAMA, 1997
- Cardiovascular Toxicity of Nicotine: Implications for Nicotine Replacement Therapy 11All editorial decisions for this article, including selection of referees, were made by a Guest Editor. This policy applies to all articles with authors from the University of California San Francisco.Journal of the American College of Cardiology, 1997
- Less-Hazardous Tobacco Use as a Treatment for the “Smoking and Health” ProblemPublished by Springer Nature ,1984
- A NEW AGE FOR SNUFF?The Lancet, 1980